Robeco Institutional Asset Management B.V. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 5.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 313,370 shares of the medical equipment provider’s stock after acquiring an additional 14,809 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Intuitive Surgical were worth $163,567,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Bennett Selby Investments LP lifted its stake in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC lifted its stake in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. lifted its stake in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its stake in shares of Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after purchasing an additional 20 shares during the last quarter. Finally, Mitchell Mcleod Pugh & Williams Inc. lifted its stake in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
ISRG has been the topic of several recent analyst reports. Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday. Finally, Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.
Intuitive Surgical Stock Performance
ISRG opened at $574.14 on Wednesday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a market cap of $204.50 billion, a P/E ratio of 92.31, a PEG ratio of 5.19 and a beta of 1.39. The business’s 50-day simple moving average is $548.70 and its 200-day simple moving average is $507.04.
Insider Activity
In related news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 28,749 shares of company stock worth $15,303,875. 0.90% of the stock is currently owned by insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- What Are the FAANG Stocks and Are They Good Investments?
- Why Salesforce Stock Could Be at Fresh Highs by February
- What is a Secondary Public Offering? What Investors Need to Know
- Talos Energy: Time to Take a Plunge Ahead of New CEO Appointment?
- Health Care Stocks Explained: Why You Might Want to Invest
- Oklo’s Fuel Partnership Strengthens Bullish Case for Stock
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.